Carolina Ghanem

Carolina Ghanem


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2016 in Pharmacological Research
Verified
Journal Article
Closed access
CGCarolina Ghanem
Carolina Ghanem
MPMaría J. Pérez
María J. Pérez
JMJosé E. Manautou
José E. Manautou
AMAldo D. Mottino
Aldo D. Mottino

17 March 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Juan Pablo RigalliJuan Pablo Rigalli
Juan Pablo Rigalli
NCNadia Ciriaci
Nadia Ciriaci
AAAgostina Arias
Agostina Arias
MCMaría Paula Ceballos
María Paula Ceballos
SVSilvina Stella Maris Villanueva
Silvina Stella Maris Villanueva
MRMaría Laura Ruiz
María Laura Ruiz
Hepatocellular carcinoma (HCC) is the fifth most frequent cancer worldwide. Sorafenib is the only drug available that improves the overall survival of HCC patients. P-glycoprotein (P-gp), Multidrug resistance-associated proteins 2 and 3 (MRP2 and 3) and Breast cancer resistance protein (BCRP) are efflux pumps that play a key role in cancer chemoresistance. Their modulation by dietary compounds may affect the intracellular accumulation and therapeutic efficacy of drugs that are substrates of these transporters. Genistein (GNT) is a phytoestrogen abundant in soybean that exerts its genomic effects through Estrogen-Receptors and Pregnane-X-Receptor (PXR), which are involved in the regulation of the above-mentioned transporters. We evaluated the effect of GNT on the expression and activity of P-gp, MRP2, MRP3 and BCRP in HCC-derived HepG2 cells. GNT (at 1.0 and 10 μM) increased P-gp and MRP2 protein expression and activity, correlating well with an increased resistance to sorafenib cytotoxicity as detected by the methylthiazole tetrazolium (MTT) assay. GNT induced P-gp and MRP2 mRNA expression at 10 but not at 1.0 μM concentration suggesting a different pattern of regulation depending on the concentration. Induction of both transporters by 1.0 μM GNT was prevented by cycloheximide, suggesting translational regulation. Downregulation of expression of the miR-379 by GNT could be associated with translational regulation of MRP2. Silencing of PXR abolished P-gp induction by GNT (at 1.0 and 10 μM) and MRP2 induction by GNT (only at 10 μM), suggesting partial mediation of GNT effects by PXR. Taken together, the data suggest the possibility of nutrient-drug interactions leading to enhanced chemoresistance in HCC when GNT is ingested with soy rich diets or dietary supplements.

1 August 2004 in Biochemical Pharmacology
Verified
Journal Article
Closed access
CGCarolina Ghanem
Carolina Ghanem
PGPaula C Gómez
Paula C Gómez
MAMarı́a C Arana
Marı́a C Arana
María PerassoloMaría Perassolo
María Perassolo
MRMarı́a L Ruiz
Marı́a L Ruiz
AMAldo D Mottino
Aldo D Mottino

1 December 2005 in The Journal of Pharmacology and Experimental Therapeutics
Verified
Journal Article
Closed access
PDF file
CGCarolina Ghanem
Carolina Ghanem
MRMaría L. Ruiz
María L. Ruiz
SVSilvina S. M. Villanueva
Silvina S. M. Villanueva
MLMarcelo G. Luquita
Marcelo G. Luquita
VCViviana A. Catania
Viviana A. Catania
AMAldo D. Mottino
Aldo D. Mottino
Despite its toxicity, acetaminophen (APAP) is used increasingly as an analgesic, antipyretic, and anti-inflammatory agent. We examined the effect of prior exposure to APAP on its biliary and urinary elimination. The biliary and urinary elimination of a test dose of APAP (150 mg/kg i.v.) was determined in male Wistar rats 24 h after pretreatment with vehicle, a single dose (1.0 g/kg i.p.), or increasing daily doses (0.2, 0.3, 0.6, and 1.0 g/kg/day i.p.) of APAP. Although elimination of the parent APAP was minimally affected, biliary excretion of APAP glucuronide was significantly decreased 70 and 80%, whereas urinary excretion was significantly increased 90 and 100% in the groups pretreated with single and repeated doses of APAP, respectively, relative to vehicle controls. Western analysis and confocal immunofluorescent microscopy indicated a marked increase in hepatic expression of multidrug resistance-associated protein 3 (Mrp3) in both groups pretreated with APAP, relative to expression of Mrp2. ATP-dependent transport of [3H]taurocholate, an Mrp3 substrate, was significantly increased in basolateral liver plasma membrane vesicles from rats pretreated with repeated doses of APAP relative to controls. Enterohepatic recirculation of APAP glucuronide after administration of the same test dose of the drug was significantly decreased in rats pretreated with repeated doses of APAP. These data indicate that APAP pretreatment induced a shift from biliary to urinary elimination of APAP glucuronide, consistent with the increased expression of Mrp3 in the basolateral domain of the hepatocyte. We postulate that decreased enterohepatic recirculation contributes to decreased APAP hepatotoxicity by reducing liver exposure.

1 May 2009 in Biochemical Pharmacology
Verified
Journal Article
Closed access
CGCarolina Ghanem
Carolina Ghanem
MRMaría L. Ruiz
María L. Ruiz
SVSilvina S.M. Villanueva
Silvina S.M. Villanueva
MLMarcelo Luquita
Marcelo Luquita
SLSusana Llesuy
Susana Llesuy
AMAldo D. Mottino
Aldo D. Mottino

1 May 2014 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
ABAlba G. Blazquez
Alba G. Blazquez
Oscar Briz SanchezOscar Briz Sanchez
Oscar Briz Sanchez
EGEster Gonzalez-Sanchez
Ester Gonzalez-Sanchez
MPMaria J. Perez
Maria J. Perez
CGCarolina Ghanem
Carolina Ghanem
Jose MarinJose Marin
Jose Marin